A study published in the Nov. 1 issue of The Journal of Bone & Joint Surgery compares the use of peripheral nerve blockade (PNB) against two variations of periarticular infiltration (PAI) as part of a multimodal analgesia pathway for total hip arthroplasty (THA). 

The authors conducted a randomized clinical trial of 159 patients who underwent THA and who received either PNB (n = 51), PAI with ropivacaine, ketorolac, and epinephrine (PAI-R; n = 54), or PAI with liposomal bupivacaine, ketorolac, and epinephrine (PAI-L; n = 54). They found that opioid consumption was low and did not differ across cohorts at any time interval. However, based on a 1-10 ascending numeric rating scale, median maximum pain on postoperative day 1 was 5.0 in the PNB group, 5.5 in the PAI-R group, and 4.0 in the PAI-L. On postoperative day 2, median maximum pain was 3.5 for the PNB group, 5.0 for the PAI-R group, and 3.5 for the PAI-L group. The authors write that the PAI-L group was not significantly different from the PNB group with respect to any outcomes: postoperative opioid use, length of stay, hospital adverse events, and 3-month follow-up data including any complication. Learn more...

Comments (0)

There are no comments posted here yet

Submit Community Content

If you have orthopedic information that you would like to share with the Orthogate Community, please register/login and submit your news, event, job, article, case or workshop from the Submit Content menu under the My Account area. Learn more!